Healthcare Innovation: The Next Frontier
Looking for feedback on your project, connections in MedTech, or a way into healthcare innovation?
Get a 360-degree view of Singapore’s landscape, from research to funding, and walk away with actionable advice.
🎤 Invited Guests
01 Dr Seow Shih Wee
✦ Chief of Staff, PRECISE
✦ Runs operations for Singapore's National Precision Medicine programme. Ask him how to work with government agencies, structure research collaboration agreements, and plug into national genomics/health-data efforts.
02 Dr Alfredo Franco-Obregón
✦ Head, BICEPS Lab, NUS Med; Founder, QuantumTx
✦ Took his NUS lab's magnetic muscle therapy from bench to a commercial device: patented, spun out as QuantumTX, trialled with SGH, and now offered at Alexandra Hospital plus 10 partner centres. The lab-to-market playbook in person.
03 Dexter Tiah
✦ Investment Manager, NUSX
✦ Helps select and manage the BLOCK71 portfolio. He knows exactly why some decks make the cut and others don't.
04 Jay Teo
✦ Entrepreneur-in-Residence, ATUM Ventures
✦ At ATUM, a venture studio that turns research from institutes and universities into medtech, energy and manufacturing startups. ✦ He asks how to make a research project a fundable company.
05 Gwendolin Mah
✦ Head of International Programs, MedTech Actuator
✦ Helps medtech startups with clinical validation, market access and international expansion, and leads MedTech Actuator's Singapore accelerator. Your go-to for going regional and global.
06 Sheam Kannan
✦ Programs Manager, MedTech Actuator
✦ Part of the team at MedTech Actuator, the Asia-Pacific medtech accelerator whose program has helped unlock $62M+ in venture funding for health startups.
07 Feng He
✦ Co-founder, MyTherapist
✦ Started in 2014, China's first mobile psychotherapy platform with over 6M users and therapists from over 117 countries.
08 Ashok Venkitaraman
✦ Director, Cancer Science Institute of Singapore.
✦ Distinguished Professor at the National University of Singapore (NUS), and Chief Scientist at A*STAR.
✦ He discovered how the "breast cancer gene" BRCA2 suppresses tumours, and turned his lab's target-discovery tech into serial Cambridge biotech spin-outs.
✨ What we’ll explore ✨
• From Lab to Real-World Use
• Driving Adoption Across Hospitals
• What Investors Look For in Early-Stage MedTech
• Going Regional and Global
🍽️ Your evening 🍽️
• Buffet dinner
• Fireside chat and Q&A
• Expert consultations: pitch and get feedback
• Networking
⚡️ Mentor Clinic⚡️
Building the next breakthrough in bio, health, or clinical tech? We’re opening exclusive consultation slots for early-stage MedTech founding teams.
• Pressure-test your thesis: Deliver a rapid-fire elevator pitch directly to our invited industry leaders.
• Instant calibration: Cut through the noise with raw, high-signal, on-the-spot feedback.
• Move the needle: Put your venture in front of high-leverage decision makers.